The Rise of AI-Native Biotech Companies

July 9, 2026

FibroGen’s DMD drug fails phase 3 clinical trial, adding to clinical troubles

June 7, 2023

FDA Issues Fresh Criticism of Novo Nordisk Indiana Manufacturing Plant

November 24, 2025

Must Read

Dysport Meets Phase 3 Goals in Episodic and Chronic Migraine Trials

July 14, 2026

J&J Reports Positive Phase 2/3 Results for Imaavy in Warm Autoimmune Hemolytic Anemia

July 11, 2026

Edgewise Reports Phase 2 CIRRUS-HCM Results for EDG-7500 Ahead of Planned Phase 3 Development

July 11, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Early research shows that Lilly’s Verve strategy is successful in lowering cholesterol

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Dysport Meets Phase 3 Goals in Episodic and Chronic Migraine Trials

J&J Reports Positive Phase 2/3 Results for Imaavy in Warm Autoimmune Hemolytic Anemia

Bausch + Lomb Ends BL1107 Glaucoma Program After Phase 2 Trial Misses Main Goal

Phase 3 KRYSTAL-10 Study Fails to Meet Primary Endpoints for Krazati in Metastatic Colorectal Cancer

Leo Cancer Care Raises $65 Million Series D Round to Expand Upright Radiotherapy Platform

Novartis Set to Buy UK Biotech Myricx For Over $1.1B

In its biggest-ever transaction, Vertex pays $10 billion to buy endocrine disease expert Crinetics

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Top 10 Barriers to Scaling Genomics Programs in Healthcare

The Rise of AI-Native Biotech Companies

Why Every Pharma Company Is Becoming a Technology Company

Top 10 Reasons Precision Medicine Requires Better Data Integration

Regulatory

FDA Under Trump Reduces Use of Advisory Committees in Drug Approvals

Editor Picks

The Rise of AI-Native Biotech Companies

FibroGen’s DMD drug fails phase 3 clinical trial, adding to clinical troubles

FDA Issues Fresh Criticism of Novo Nordisk Indiana Manufacturing Plant

Must Read

Dysport Meets Phase 3 Goals in Episodic and Chronic Migraine Trials

J&J Reports Positive Phase 2/3 Results for Imaavy in Warm Autoimmune Hemolytic Anemia

Edgewise Reports Phase 2 CIRRUS-HCM Results for EDG-7500 Ahead of Planned Phase 3 Development

Hot Topics

About Us

Follow Us